KitsadaWudhikarnMD

PubMed

• 1 citations
  Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma.
  Karthik Nath, Kitsada Wudhikarn, Ana Alarcon Tomas, Miguel-Angel Perales> ;Expert Opinion on Drug Safety. 2023 Jan 1
• 1 citations
  Outcomes of Older Adults with Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Mayo Clinic Cohort Analysis.
  Kitsada Wudhikarn, Bradley M Johnson, David J Inwards, Luis F Porrata, Ivana N Micallef, Stephen M Ansell, Willam J Hogan, Jonas Paludo, Jose C Villasboas, Patrick B J...> ;Transplantation and Cellular Therapy. 2023 Mar 1
• 31 citations
  Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy.
  Kitsada Wudhikarn, Miguel-Angel Perales> ;Bone Marrow Transplantation. 2022 Oct 1
• Immune dysregulation in extranodal NK/T cell lymphomas: potential roles in pathogenesis and immunotherapy.
  Chantana Polprasert, Kitsada Wudhikarn, Ponlapat Rojnuckarin> ;Blood Research. 2021 Nov 12
• Toxicity of Chimeric Antigen Receptor T Cells and its Management.
  Kitsada Wudhikarn, Shui Yen Soh, He Huang, Miguel-Angel Perales> ;Blood Cell Therapy. 2021 Oct 14
• 7 citations
  Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel.
  Kitsada Wudhikarn, Radhika Bansal, Arushi Khurana, Matthew A. Hathcock, Sherri A. Braksick, N. Nora Bennani, Jonas Paludo, Jose C. Villasboas, Yucai Wang, Patrick B. J...> ;American Journal of Hematology. 2021 Nov 1
• 15 citations
  Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
  Emma C. St. Martin, Alejandro Ferrer, Abhishek A. Mangaonkar, Shakila P. Khan, Mira A. Kohorst, Avni Y. Joshi, William J. Hogan, Horatiu Olteanu, Ann M. Moyer, Aref Al...> ;American Journal of Hematology. 2021 Aug 14
• 4 citations
  How to Sequence Therapies in Peripheral T Cell Lymphoma
  Kitsada Wudhikarn, N. Nora Bennani> ;Current Treatment Options in Oncology. 2021 Jul 2
• 7 citations
  The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel.
  Kitsada Wudhikarn, Radhika Bansal, Arushi Khurana, Matthew A. Hathcock, N. Nora Bennani, Jonas Paludo, Jose C. Villasboas, Yucai Wang, Patrick B. Johnston, Stephen M. ...> ;Blood Cancer Journal. 2021 Jul 1
• 4 citations
  Clinical features and survival outcomes in patients with chronic myelomonocytic leukemia arising in the context of germline predisposition syndromes
  Emma C. St. Martin, Alejandro Ferrer, Kitsada Wudhikarn, Abhishek A. Mangaonkar, William J. Hogan, Ayalew Tefferi, Naseema Gangat, Terra L. Lasho, Jessica K. Altman, L...> ;American Journal of Hematology. 2021 May 24
• Isolated Extramedullary Relapse After Human Leukocyte Antigen-Matched Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patien...
  Photsawee Khemaphiphat, Kitsada Wudhikarn, Udomsak Bunworasate, Chantiya Chanswangphuwana> ;Transplantation Proceedings. 2021 May 4
• 36 citations
  Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
  Kitsada Wudhikarn, Jessica Flynn, Isabelle Riviere, Mithat Gonen, Xiuyan Wang, Brigitte Senechal, Kevin J. Curran, Mikhail Roshal, Peter Maslak, Mark B. Geyer, Elizabe...> ;Blood. 2021 Aug 19
• 23 citations
  The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy
  Marta Garcia-Recio, Kitsada Wudhikarn, Martina Pennisi, Rosalia Alonso-Trillo, Jessica Flynn, Roni Shouval, Aishat Afuye, Mari Lynne Silverberg, Connie W. Batlevi, Par...> ;Transplantation and Cellular Therapy. 2021 Mar 1
• 12 citations
  Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide mainten...
  Kitsada Wudhikarn, Leslie Padrnos, Terra L. Lasho, Betsy LaPlant, Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, S. Vincent Rajkumar, Morie A. Gertz, Abhishek A. Man...> ;American Journal of Hematology. 2021 Feb 13
• 8 citations
  Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas.
  Chantana Polprasert, Yasuhide Takeuchi, Hideki Makishima, Kitsada Wudhikarn, Nobuyuki Kakiuchi, Nichthida Tangnuntachai, Thamathorn Assanasen, Wimonmas Sitthi, Hamidah...> ;Leukemia & Lymphoma. 2021 Jan 2
• 19 citations
  Future of CAR T cells in multiple myeloma.
  Kitsada Wudhikarn, Sham Mailankody, Eric L. Smith> ;Hematology. American Society of Hematology. Education Program. 2020 Dec 4
• 16 citations
  SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survival
  Kitsada Wudhikarn, Sanam Loghavi, Abhishek A. Mangaonkar, Aref Al-Kali, Moritz Binder, Ryan M. Carr, Kaaren K. Reichard, Christy Finke, Matthew T. Howard, Naseema Gang...> ;Blood Advances. 2020 Nov 24
• 3 citations
  The influence of programmed cell death ligand 2 (PD-L2) expression on survival outcome and tumor microenvironment in diffuse large B cell lymphoma.
  San Krittikarux, Kitsada Wudhikarn, Nichthida Tangnuntachai, Thamathorn Assanasen, Narittee Sukswai, Thiti Asawapanumas, Chantiya Chanswangphuwana> ;Leukemia & Lymphoma. 2020 Aug 21
• 117 citations
  Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
  Kitsada Wudhikarn, M. Lia Palomba, Martina Pennisi, Marta Garcia-Recio, Jessica Flynn, Sean M. Devlin, Aishat Afuye, Mari Lynne Silverberg, Molly Maloy, Gunjan L. Shah...> ;Blood Cancer Journal. 2020 Aug 5
• 64 citations
  DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
  Kitsada Wudhikarn, Martina Pennisi, Marta Garcia-Recio, Jessica Flynn, Aishat Afuye, Mari Lynne Silverberg, Molly Maloy, Sean M. Devlin, Connie L Batlevi, Gunjan L. Sh...> ;Blood Advances. 2020 Jul 14
• 1 citations
  Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group.
  Kitsada Wudhikarn, Udomsak Bunworasate, Jakrawadee Julamanee, Arnuparp Lekhakula, Supachai Ekwattanakit, Archrob Khuhapinant, Pimjai Niparuck, Suporn Chuncharunee, Ton...> ;Leukemia & Lymphoma. 2020 Jun 23
• 5 citations
  Dissecting factors influencing response to CAR T cell therapy in B lymphoid hematologic malignancies: from basic to practice.
  Kitsada Wudhikarn, Jae H. Park> ;Leukemia & Lymphoma. 2020 Jun 10
• 26 citations
  Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of action.
  Kitsada Wudhikarn, Beatriz Wills, Alexander M. Lesokhin> ;Best Practice & Research. Clinical Haematology. 2020 Jan 11
• 96 citations
  Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management.
  Martina Pennisi, Tania Jain, Bianca Santomasso, Elena Mead, Kitsada Wudhikarn, Mari Lynne Silverberg, Yakup Batlevi, Roni Shouval, Sean M. Devlin, Connie L Batlevi, Re...> ;Blood Advances. 2020 Feb 25
• 16 citations
  Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant.
  Kapoor, U., Kapoor, U., Kapoor, U., , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Leukemia. 2020 Feb 4
• Join now to see all